ANVISA registration

Parvovirus Virclia IgM Monotest

Registration 10259610241. PARVOVÍRUS B 19

Registration details

Registration number10259610241
Application number25351155471202308
Technical namePARVOVÍRUS B 19
Risk classIII
Published on27/03/2023
ValidityValid until 15/10/2028

Registration holder

Legal nameMEDIVAX INDÚSTRIA E COMÉRCIO LTDA
CNPJ68.814.961/0001-73

Manufacturer

  • VIRCELL S.L. ESPANHA

Other registrations held by MEDIVAX INDÚSTRIA E COMÉRCIO LTDAview all

ROTASCREEN II EIA

10225960008

ANTICORPOS ANTI-MITOCONDRIA IMUNOFLUORESCENCIA

10225960020

ANTICORPOS ANTI-nDNA IMUNOFLUORESCENCIA

10225960022

AUTO-SCREEN (TRIAGEM AUTOIMUNE) IMUNOFLUORESCENCIA

10225960025

SMA ANTICORPOS ANTI-MUSCULO LISO IMUNOFLUORESCENCIA

10225960026

ANCA IMUNOFLUORESCENCIA

10225960028

Source: ANVISA

Source: ANVISA open data, medical device file, updated daily. The public database provides registration validity, rather than registration status: this registration may have been cancelled before its expiry date without this being shown here. Before making purchasing, import or marketing decisions, check the ANVISA search portal.

Next step

Medical device registration with ANVISA

HSC manages the process from risk classification to liaising with the regulator, in Brazil and more than 40 other countries.

Speak to a specialist